Biomarkers (3)
Categories
Hormones, Thyroid & Reproductive Health
12 biomarkers
Other matches
thyroglobulin
thyroid peroxidase (TPOAb)
thyroid antibodies
Explore the key areas of your health we measure and monitor.
Hormones, Thyroid & Reproductive Health
Metabolic and cardiovascular health
Inflammation and Immunities
Organ Function and detoxification
Lifestyle, general and well-being
A focused look at hormone balance, thyroid function, and reproductive health markers that influence energy, mood, metabolism, and long-term wellbeing.
1/year
Thyroid-stimulating hormone from the pituitary. Abnormal levels indicate primary or secondary thyroid dysfunction.
Add-on
Thyroid peroxidase antibodies (TPO): A laboratory measurement. Consult clinical resources for specific interpretation.
Add-on
Thyroglobulin antibodies (TgAb) are immune proteins measured in blood to help detect autoimmune thyroid disorders.
1/year
Unbound testosterone available to tissues. More directly correlates with androgenic effects than total testosterone.
1/year
Total circulating testosterone (bound + free). Indicates androgen status, fertility, and endocrine health.
1/year
Sex hormone-binding globulin produced by liver; binds sex hormones and modulates their bioavailability.
Add-on
A blood test that measures total PSA and the proportion of free PSA to help assess prostate health and cancer risk.
Add-on
Pituitary hormone involved in lactation and reproductive regulation. Elevated prolactin can cause infertility or galactorrhea.
Add-on
Luteinizing hormone from pituitary stimulating ovulation in women and testosterone production in men.
Add-on
Active thyroid hormone affecting metabolism. Used in detailed thyroid evaluation.
1/year
Unbound thyroxine hormone. Low levels suggest hypothyroidism, high indicate hyperthyroidism.
Add-on
Follicle-stimulating hormone driving follicle development and spermatogenesis. Abnormal levels indicate gonadal dysfunction.
1/year
Primary estrogen regulating reproductive and bone health. Levels vary by sex, age, and cycle phase.
1/year
Adrenal steroid precursor reflecting adrenal androgen production. Altered levels occur in adrenal or gonadal disorders.
1/year
Morning cortisol reflecting HPA axis activity. Abnormal levels indicate adrenal dysfunction or stress adaptation issues.
Gain a deeper understanding of your heart and metabolic health through biomarkers that assess cholesterol, blood sugar regulation, cardiovascular risk, and overall metabolic performance.
1/year
The arachidonic acid to EPA ratio (AA/EPA) assesses the balance between pro-inflammatory omega-6 and anti-inflammatory omega-3 fatty acids at the cellular level. Lower ratios indicate better inflammatory balance, while elevated ratios suggest increased inflammatory potential and are associated with various chronic diseases.
1/year
End-product of purine metabolism. Elevated levels increase risk of gout and may signal metabolic dysfunction.
2/year
Circulating fats used for energy. Elevated levels are associated with metabolic syndrome and cardiovascular risk.
2/year
Sum of cholesterol across lipoproteins. Higher levels correlate with increased cardiovascular risk.
2/year
Number of circulating erythrocytes. Deviations indicate anemia, marrow disorders, or dehydration.
1/year
The Rhesus (Rh) factor is a protein found on the surface of red blood cells that determines whether a person’s blood type is Rh-positive or Rh-negative. Important for transfusion safety and pregnancy management.
2/year
Red cell distribution width (RDW): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Number of platelets, essential for clotting. Low counts risk bleeding, high counts risk thrombosis.
1/year
A blood measurement of linoleic acid, an essential omega-6 fatty acid important for cell structure and energy metabolism.
1/year
A blood measurement of arachidonic acid, an omega-6 fatty acid involved in inflammation and cellular signaling.
1/year
A blood test that measures total omega-6 fatty acids, which are essential fats involved in energy production, cell signaling, and inflammatory processes.
1/year
A blood or lipid-based measure that compares omega-6 fatty acids to omega-3 fatty acids, indicating balance between pro- and anti-inflammatory fats.
1/year
A blood measurement of eicosapentaenoic acid (EPA), an omega-3 fatty acid linked to anti-inflammatory and cardiovascular support.
1/year
A blood measurement of docosapentaenoic acid (DPA), a lesser-known omega-3 fatty acid that acts as an intermediate between EPA and DHA.
1/year
A laboratory measurement of docosahexaenoic acid (DHA), an essential omega-3 fatty acid important for brain, eye, and cardiovascular health.
1/year
A blood test that measures overall omega-3 fatty acid levels, mainly EPA and DHA, to assess nutritional and cardiovascular health status.
2/year
High-density lipoprotein involved in reverse cholesterol transport. Higher HDL is generally protective.
2/year
Average platelet size. Higher MPV indicates younger, more reactive platelets often seen with increased turnover.
2/year
Average red blood cell size. Helps classify anemia as microcytic, normocytic, or macrocytic.
2/year
Average concentration of hemoglobin in red blood cells. Used in anemia evaluation.
2/year
Average hemoglobin amount per red blood cell. Useful for classifying anemias.
Add-on
A genetically determined lipoprotein particle similar to LDL that is associated with increased cardiovascular risk.
1/year
Leptin: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
A measurement of the concentration of small, dense LDL particles in the blood.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
A classification of LDL particles based on their size and density, indicating cardiovascular risk.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
A subclass of low-density lipoprotein (LDL) particles of intermediate size, associated with cardiovascular risk assessment.
1/year
A blood test that measures the body’s capacity to bind and transport iron, reflecting transferrin availability.
1/year
Serum iron measures circulating iron bound to transferrin. Low in iron deficiency, high in overload.
1/year
Iron % saturation: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Pancreatic hormone regulating glucose uptake. Fasting hyperinsulinemia suggests insulin resistance.
2/year
Average glycemia over prior 8–12 weeks. Used to diagnose and monitor diabetes management.
2/year
Oxygen-carrying protein in red blood cells. Low hemoglobin indicates anemia and reduced oxygen delivery. High levels may reflect dehydration or polycythemia.
2/year
The proportion of blood volume occupied by red blood cells. Low values indicate anemia. High values suggest dehydration or polycythemia.
2/year
HDL-Cholesterol: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
HDL Large refers to the larger, more protective subfraction of high-density lipoprotein (HDL) particles involved in cholesterol transport.
2/year
Serum glucose is the level of sugar in the blood and serves as the body’s primary source of energy.
1/year
Iron storage protein indicating iron stores. Low ferritin indicates deficiency, high may reflect inflammation or iron overload.
2/year
An algorithmic estimate of physiological age derived from biomarker patterns and clinical data. Used to track aging-related changes relative to chronological age.
2/year
Structural protein on atherogenic lipoproteins. Reflects particle number and cardiovascular risk.
1/year
Determines blood type (A, B, AB, O) based on surface antigens.
Essential for transfusions and transplant compatibility.
Assess biomarkers linked to brain function, neurological health, nutrient status, and factors that influence memory, focus, mood, and cognitive performance.
2/year
Urine white blood cells (WBCs) measure the presence of immune cells in urine to help detect infection or inflammation in the urinary tract.
1/year
An autoantibody associated with rheumatoid arthritis and other autoimmune diseases. Presence supports diagnosis but is not specific.
2/year
Proportion of monocytes, white cells involved in phagocytosis and inflammation. Elevations indicate chronic inflammation or recovery from infection.
2/year
Proportion of neutrophils among white cells. Elevation suggests bacterial infection or stress. Low levels increase infection risk.
2/year
Proportion of lymphocytes among white cells. Changes reflect viral infections, chronic inflammation, or immune disorders.
2/year
High-sensitivity C-reactive protein (hs-CRP): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Proportion of eosinophils, associated with allergic responses and parasitic infections.
2/year
A key electrolyte that reflects bicarbonate levels and helps regulate the body’s acid–base (pH) balance.
2/year
Proportion of basophils, involved in allergic reactions and histamine release.
1/year
A test detecting autoantibodies against nuclear components. Positive ANA suggests autoimmune conditions like SLE but requires clinical correlation.
Monitor the health of your body's vital organs through biomarkers that assess liver and kidney function, detoxification pathways, and overall physiological performance to support long-term wellbeing.
2/year
A measure of how acidic or alkaline urine is, expressed on a scale from 0 to 14.
2/year
Total protein is a blood test that measures the combined amount of proteins in the blood, mainly albumin and globulin, to assess overall health.
2/year
Total bilirubin is a blood test that measures the amount of bilirubin to assess liver function and red blood cell breakdown.
2/year
Urine specific gravity measures the concentration of urine to assess hydration status and kidney function.
2/year
Principal extracellular cation essential for fluid balance and neuromuscular function. Abnormalities suggest hydration or renal/endocrine issues.
2/year
Principal extracellular cation essential for fluid balance and neuromuscular function. Abnormalities suggest hydration or renal/endocrine issues.
2/year
A urine protein test measures the amount of protein present in urine to help assess kidney function and detect possible health issues.
2/year
Key intracellular cation for cardiac and neuromuscular function. Imbalances can cause arrhythmias and muscle dysfunction.
2/year
Key intracellular cation for cardiac and neuromuscular function. imbalances can cause arrhythmias and muscle dysfunction.
2/year
A urine test that detects hidden (non-visible) blood in urine, indicating possible bleeding or urinary tract disorders.
2/year
A urine test marker that detects the presence of nitrites, which often indicate bacterial infection in the urinary tract.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
2/year
The presence of white blood cells (leukocytes) in urine, typically used as an indicator of infection or inflammation in the urinary tract.
1/year
An enzyme primarily produced by the pancreas that helps break down dietary fats and is measured in blood to assess pancreatic function.
2/year
A urine test that detects ketones, indicating fat breakdown for energy instead of glucose.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Primary circulating sugar. Fasting elevation signals insulin resistance, prediabetes, or diabetes.
2/year
Globulin: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
Gamma‑glutamyl transferase, sensitive to biliary injury and alcohol exposure. Elevated in cholestasis.
2/year
Estimated glomerular filtration rate assessing kidney filtration capacity. Lower values indicate impaired renal function.
2/year
A muscle metabolism byproduct cleared by kidneys. Elevated serum creatinine suggests reduced glomerular filtration.
2/year
Urine color is a visual indicator of hydration status and possible underlying health conditions.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Carbon dioxide (bicarbonate, CO₂): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Urea concentration reflecting protein metabolism and renal excretion. Elevated in renal impairment or volume depletion.
2/year
A urine marker that detects bilirubin, a byproduct of red blood cell breakdown, used to assess liver and bile duct health.
2/year
Aspartate aminotransferase (AST): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A visual assessment of urine clarity and color used to provide initial insights into hydration and possible health conditions.
1/year
An enzyme that helps digest carbohydrates and is commonly used to assess pancreatic health.
1/year
A blood test ratio that compares albumin and globulin levels to assess liver function, immune status, and overall protein balance.
2/year
Primary plasma protein synthesized by the liver. Maintains oncotic pressure and transports small molecules. Low levels suggest liver disease or malnutrition.
2/year
Enzyme from liver and bone. Elevated in cholestasis, bone turnover, or biliary obstruction.
1/year
A urine test that measures small amounts of albumin to detect early kidney damage.
2/year
A liver enzyme that helps convert proteins into energy and is a key marker of liver health.
Understand the biomarkers that reflect your overall health, nutritional status, and lifestyle habits, helping you build a stronger foundation for energy, resilience, healthy ageing, and everyday performance.
1/year
Zinc is an essential trace mineral measured in blood to evaluate nutritional status, immune function, and metabolic health.
1/year
Main circulating form of vitamin D reflecting status from sun exposure and intake. Deficiency affects bone and immune health.
Add-on
A metabolic byproduct measured in blood or urine that helps assess vitamin B12 status.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
Add-on
Amino acid linked to B‑vitamin metabolism. Elevated levels associate with vascular risk and methylation defects.
1/year
Thyroid-stimulating hormone from the pituitary. Abnormal levels indicate primary or secondary thyroid dysfunction.
Add-on
Thyroid peroxidase antibodies (TPO): A laboratory measurement. Consult clinical resources for specific interpretation.
Add-on
Thyroglobulin antibodies (TgAb) are immune proteins measured in blood to help detect autoimmune thyroid disorders.
1/year
Unbound testosterone available to tissues. More directly correlates with androgenic effects than total testosterone.
1/year
Total circulating testosterone (bound + free). Indicates androgen status, fertility, and endocrine health.
1/year
Sex hormone-binding globulin produced by liver; binds sex hormones and modulates their bioavailability.
Add-on
A blood test that measures total PSA and the proportion of free PSA to help assess prostate health and cancer risk.
Add-on
Pituitary hormone involved in lactation and reproductive regulation. Elevated prolactin can cause infertility or galactorrhea.
Add-on
Luteinizing hormone from pituitary stimulating ovulation in women and testosterone production in men.
Add-on
Active thyroid hormone affecting metabolism. Used in detailed thyroid evaluation.
1/year
Unbound thyroxine hormone. Low levels suggest hypothyroidism, high indicate hyperthyroidism.
Add-on
Follicle-stimulating hormone driving follicle development and spermatogenesis. Abnormal levels indicate gonadal dysfunction.
1/year
Primary estrogen regulating reproductive and bone health. Levels vary by sex, age, and cycle phase.
1/year
Adrenal steroid precursor reflecting adrenal androgen production. Altered levels occur in adrenal or gonadal disorders.
1/year
Morning cortisol reflecting HPA axis activity. Abnormal levels indicate adrenal dysfunction or stress adaptation issues.
1/year
The arachidonic acid to EPA ratio (AA/EPA) assesses the balance between pro-inflammatory omega-6 and anti-inflammatory omega-3 fatty acids at the cellular level. Lower ratios indicate better inflammatory balance, while elevated ratios suggest increased inflammatory potential and are associated with various chronic diseases.
1/year
End-product of purine metabolism. Elevated levels increase risk of gout and may signal metabolic dysfunction.
2/year
Circulating fats used for energy. Elevated levels are associated with metabolic syndrome and cardiovascular risk.
2/year
Sum of cholesterol across lipoproteins. Higher levels correlate with increased cardiovascular risk.
2/year
Number of circulating erythrocytes. Deviations indicate anemia, marrow disorders, or dehydration.
1/year
The Rhesus (Rh) factor is a protein found on the surface of red blood cells that determines whether a person’s blood type is Rh-positive or Rh-negative. Important for transfusion safety and pregnancy management.
2/year
Red cell distribution width (RDW): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Number of platelets, essential for clotting. Low counts risk bleeding, high counts risk thrombosis.
1/year
A blood measurement of linoleic acid, an essential omega-6 fatty acid important for cell structure and energy metabolism.
1/year
A blood measurement of arachidonic acid, an omega-6 fatty acid involved in inflammation and cellular signaling.
1/year
A blood test that measures total omega-6 fatty acids, which are essential fats involved in energy production, cell signaling, and inflammatory processes.
1/year
A blood or lipid-based measure that compares omega-6 fatty acids to omega-3 fatty acids, indicating balance between pro- and anti-inflammatory fats.
1/year
A blood measurement of eicosapentaenoic acid (EPA), an omega-3 fatty acid linked to anti-inflammatory and cardiovascular support.
1/year
A blood measurement of docosapentaenoic acid (DPA), a lesser-known omega-3 fatty acid that acts as an intermediate between EPA and DHA.
1/year
A laboratory measurement of docosahexaenoic acid (DHA), an essential omega-3 fatty acid important for brain, eye, and cardiovascular health.
1/year
A blood test that measures overall omega-3 fatty acid levels, mainly EPA and DHA, to assess nutritional and cardiovascular health status.
2/year
High-density lipoprotein involved in reverse cholesterol transport. Higher HDL is generally protective.
2/year
Average platelet size. Higher MPV indicates younger, more reactive platelets often seen with increased turnover.
2/year
Average red blood cell size. Helps classify anemia as microcytic, normocytic, or macrocytic.
2/year
Average concentration of hemoglobin in red blood cells. Used in anemia evaluation.
2/year
Average hemoglobin amount per red blood cell. Useful for classifying anemias.
Add-on
A genetically determined lipoprotein particle similar to LDL that is associated with increased cardiovascular risk.
1/year
Leptin: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
A measurement of the concentration of small, dense LDL particles in the blood.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
A classification of LDL particles based on their size and density, indicating cardiovascular risk.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
A subclass of low-density lipoprotein (LDL) particles of intermediate size, associated with cardiovascular risk assessment.
1/year
A blood test that measures the body’s capacity to bind and transport iron, reflecting transferrin availability.
1/year
Serum iron measures circulating iron bound to transferrin. Low in iron deficiency, high in overload.
1/year
Iron % saturation: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Pancreatic hormone regulating glucose uptake. Fasting hyperinsulinemia suggests insulin resistance.
2/year
Average glycemia over prior 8–12 weeks. Used to diagnose and monitor diabetes management.
2/year
Oxygen-carrying protein in red blood cells. Low hemoglobin indicates anemia and reduced oxygen delivery. High levels may reflect dehydration or polycythemia.
2/year
The proportion of blood volume occupied by red blood cells. Low values indicate anemia. High values suggest dehydration or polycythemia.
2/year
HDL-Cholesterol: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
HDL Large refers to the larger, more protective subfraction of high-density lipoprotein (HDL) particles involved in cholesterol transport.
2/year
Serum glucose is the level of sugar in the blood and serves as the body’s primary source of energy.
1/year
Iron storage protein indicating iron stores. Low ferritin indicates deficiency, high may reflect inflammation or iron overload.
2/year
An algorithmic estimate of physiological age derived from biomarker patterns and clinical data. Used to track aging-related changes relative to chronological age.
2/year
Structural protein on atherogenic lipoproteins. Reflects particle number and cardiovascular risk.
1/year
Determines blood type (A, B, AB, O) based on surface antigens.
Essential for transfusions and transplant compatibility.
2/year
Urine white blood cells (WBCs) measure the presence of immune cells in urine to help detect infection or inflammation in the urinary tract.
1/year
An autoantibody associated with rheumatoid arthritis and other autoimmune diseases. Presence supports diagnosis but is not specific.
2/year
Proportion of monocytes, white cells involved in phagocytosis and inflammation. Elevations indicate chronic inflammation or recovery from infection.
2/year
Proportion of neutrophils among white cells. Elevation suggests bacterial infection or stress. Low levels increase infection risk.
2/year
Proportion of lymphocytes among white cells. Changes reflect viral infections, chronic inflammation, or immune disorders.
2/year
High-sensitivity C-reactive protein (hs-CRP): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Proportion of eosinophils, associated with allergic responses and parasitic infections.
2/year
A key electrolyte that reflects bicarbonate levels and helps regulate the body’s acid–base (pH) balance.
2/year
Proportion of basophils, involved in allergic reactions and histamine release.
1/year
A test detecting autoantibodies against nuclear components. Positive ANA suggests autoimmune conditions like SLE but requires clinical correlation.
2/year
A measure of how acidic or alkaline urine is, expressed on a scale from 0 to 14.
2/year
Total protein is a blood test that measures the combined amount of proteins in the blood, mainly albumin and globulin, to assess overall health.
2/year
Total bilirubin is a blood test that measures the amount of bilirubin to assess liver function and red blood cell breakdown.
2/year
Urine specific gravity measures the concentration of urine to assess hydration status and kidney function.
2/year
Principal extracellular cation essential for fluid balance and neuromuscular function. Abnormalities suggest hydration or renal/endocrine issues.
2/year
Principal extracellular cation essential for fluid balance and neuromuscular function. Abnormalities suggest hydration or renal/endocrine issues.
2/year
A urine protein test measures the amount of protein present in urine to help assess kidney function and detect possible health issues.
2/year
Key intracellular cation for cardiac and neuromuscular function. Imbalances can cause arrhythmias and muscle dysfunction.
2/year
Key intracellular cation for cardiac and neuromuscular function. imbalances can cause arrhythmias and muscle dysfunction.
2/year
A urine test that detects hidden (non-visible) blood in urine, indicating possible bleeding or urinary tract disorders.
2/year
A urine test marker that detects the presence of nitrites, which often indicate bacterial infection in the urinary tract.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
2/year
The presence of white blood cells (leukocytes) in urine, typically used as an indicator of infection or inflammation in the urinary tract.
1/year
An enzyme primarily produced by the pancreas that helps break down dietary fats and is measured in blood to assess pancreatic function.
2/year
A urine test that detects ketones, indicating fat breakdown for energy instead of glucose.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Primary circulating sugar. Fasting elevation signals insulin resistance, prediabetes, or diabetes.
2/year
Globulin: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
Gamma‑glutamyl transferase, sensitive to biliary injury and alcohol exposure. Elevated in cholestasis.
2/year
Estimated glomerular filtration rate assessing kidney filtration capacity. Lower values indicate impaired renal function.
2/year
A muscle metabolism byproduct cleared by kidneys. Elevated serum creatinine suggests reduced glomerular filtration.
2/year
Urine color is a visual indicator of hydration status and possible underlying health conditions.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Carbon dioxide (bicarbonate, CO₂): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Urea concentration reflecting protein metabolism and renal excretion. Elevated in renal impairment or volume depletion.
2/year
A urine marker that detects bilirubin, a byproduct of red blood cell breakdown, used to assess liver and bile duct health.
2/year
Aspartate aminotransferase (AST): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A visual assessment of urine clarity and color used to provide initial insights into hydration and possible health conditions.
1/year
An enzyme that helps digest carbohydrates and is commonly used to assess pancreatic health.
1/year
A blood test ratio that compares albumin and globulin levels to assess liver function, immune status, and overall protein balance.
2/year
Primary plasma protein synthesized by the liver. Maintains oncotic pressure and transports small molecules. Low levels suggest liver disease or malnutrition.
2/year
Enzyme from liver and bone. Elevated in cholestasis, bone turnover, or biliary obstruction.
1/year
A urine test that measures small amounts of albumin to detect early kidney damage.
2/year
A liver enzyme that helps convert proteins into energy and is a key marker of liver health.
1/year
Zinc is an essential trace mineral measured in blood to evaluate nutritional status, immune function, and metabolic health.
1/year
Main circulating form of vitamin D reflecting status from sun exposure and intake. Deficiency affects bone and immune health.
Add-on
A metabolic byproduct measured in blood or urine that helps assess vitamin B12 status.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
Add-on
Amino acid linked to B‑vitamin metabolism. Elevated levels associate with vascular risk and methylation defects.
The arachidonic acid to EPA ratio (AA/EPA) assesses the balance between pro-inflammatory omega-6 and anti-inflammatory omega-3 fatty acids at the cellular level. Lower ratios indicate better inflammatory balance, while elevated ratios suggest increased inflammatory potential and are associated with various chronic diseases.
A measure of how acidic or alkaline urine is, expressed on a scale from 0 to 14.
Zinc is an essential trace mineral measured in blood to evaluate nutritional status, immune function, and metabolic health.
Urine white blood cells (WBCs) measure the presence of immune cells in urine to help detect infection or inflammation in the urinary tract.
Main circulating form of vitamin D reflecting status from sun exposure and intake. Deficiency affects bone and immune health.
End-product of purine metabolism. Elevated levels increase risk of gout and may signal metabolic dysfunction.
Circulating fats used for energy. Elevated levels are associated with metabolic syndrome and cardiovascular risk.
Total protein is a blood test that measures the combined amount of proteins in the blood, mainly albumin and globulin, to assess overall health.
Sum of cholesterol across lipoproteins. Higher levels correlate with increased cardiovascular risk.
Total bilirubin is a blood test that measures the amount of bilirubin to assess liver function and red blood cell breakdown.
Thyroid-stimulating hormone from the pituitary. Abnormal levels indicate primary or secondary thyroid dysfunction.
Thyroid peroxidase antibodies (TPO): A laboratory measurement. Consult clinical resources for specific interpretation.
Thyroglobulin antibodies (TgAb) are immune proteins measured in blood to help detect autoimmune thyroid disorders.
Unbound testosterone available to tissues. More directly correlates with androgenic effects than total testosterone.
Total circulating testosterone (bound + free). Indicates androgen status, fertility, and endocrine health.
Urine specific gravity measures the concentration of urine to assess hydration status and kidney function.
Principal extracellular cation essential for fluid balance and neuromuscular function. Abnormalities suggest hydration or renal/endocrine issues.
Principal extracellular cation essential for fluid balance and neuromuscular function. Abnormalities suggest hydration or renal/endocrine issues.
Sex hormone-binding globulin produced by liver; binds sex hormones and modulates their bioavailability.
An autoantibody associated with rheumatoid arthritis and other autoimmune diseases. Presence supports diagnosis but is not specific.
Number of circulating erythrocytes. Deviations indicate anemia, marrow disorders, or dehydration.
The Rhesus (Rh) factor is a protein found on the surface of red blood cells that determines whether a person’s blood type is Rh-positive or Rh-negative. Important for transfusion safety and pregnancy management.
Red cell distribution width (RDW): A laboratory measurement. Consult clinical resources for specific interpretation.
A urine protein test measures the amount of protein present in urine to help assess kidney function and detect possible health issues.
A blood test that measures total PSA and the proportion of free PSA to help assess prostate health and cancer risk.
Pituitary hormone involved in lactation and reproductive regulation. Elevated prolactin can cause infertility or galactorrhea.
Key intracellular cation for cardiac and neuromuscular function. Imbalances can cause arrhythmias and muscle dysfunction.
Key intracellular cation for cardiac and neuromuscular function. imbalances can cause arrhythmias and muscle dysfunction.
Number of platelets, essential for clotting. Low counts risk bleeding, high counts risk thrombosis.
A blood measurement of linoleic acid, an essential omega-6 fatty acid important for cell structure and energy metabolism.
A blood measurement of arachidonic acid, an omega-6 fatty acid involved in inflammation and cellular signaling.
A blood test that measures total omega-6 fatty acids, which are essential fats involved in energy production, cell signaling, and inflammatory processes.
A blood or lipid-based measure that compares omega-6 fatty acids to omega-3 fatty acids, indicating balance between pro- and anti-inflammatory fats.
A blood measurement of eicosapentaenoic acid (EPA), an omega-3 fatty acid linked to anti-inflammatory and cardiovascular support.
A blood measurement of docosapentaenoic acid (DPA), a lesser-known omega-3 fatty acid that acts as an intermediate between EPA and DHA.
A laboratory measurement of docosahexaenoic acid (DHA), an essential omega-3 fatty acid important for brain, eye, and cardiovascular health.
A blood test that measures overall omega-3 fatty acid levels, mainly EPA and DHA, to assess nutritional and cardiovascular health status.
A urine test that detects hidden (non-visible) blood in urine, indicating possible bleeding or urinary tract disorders.
A urine test marker that detects the presence of nitrites, which often indicate bacterial infection in the urinary tract.
High-density lipoprotein involved in reverse cholesterol transport. Higher HDL is generally protective.
Proportion of monocytes, white cells involved in phagocytosis and inflammation. Elevations indicate chronic inflammation or recovery from infection.
Proportion of neutrophils among white cells. Elevation suggests bacterial infection or stress. Low levels increase infection risk.
A metabolic byproduct measured in blood or urine that helps assess vitamin B12 status.
Mercury: A laboratory measurement. Consult clinical resources for specific interpretation.
Average platelet size. Higher MPV indicates younger, more reactive platelets often seen with increased turnover.
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
Average red blood cell size. Helps classify anemia as microcytic, normocytic, or macrocytic.
Average concentration of hemoglobin in red blood cells. Used in anemia evaluation.
Average hemoglobin amount per red blood cell. Useful for classifying anemias.
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
Proportion of lymphocytes among white cells. Changes reflect viral infections, chronic inflammation, or immune disorders.
Luteinizing hormone from pituitary stimulating ovulation in women and testosterone production in men.
A genetically determined lipoprotein particle similar to LDL that is associated with increased cardiovascular risk.
The presence of white blood cells (leukocytes) in urine, typically used as an indicator of infection or inflammation in the urinary tract.
An enzyme primarily produced by the pancreas that helps break down dietary fats and is measured in blood to assess pancreatic function.
Leptin: A laboratory measurement. Consult clinical resources for specific interpretation.
A measurement of the amount of lead present in the blood, used to assess exposure to this toxic heavy metal.
A laboratory measurement. Consult clinical resources for specific interpretation.
A measurement of the concentration of small, dense LDL particles in the blood.
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
A classification of LDL particles based on their size and density, indicating cardiovascular risk.
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
A subclass of low-density lipoprotein (LDL) particles of intermediate size, associated with cardiovascular risk assessment.
A blood test that measures the body’s capacity to bind and transport iron, reflecting transferrin availability.
A urine test that detects ketones, indicating fat breakdown for energy instead of glucose.
Serum iron measures circulating iron bound to transferrin. Low in iron deficiency, high in overload.
Iron % saturation: A laboratory measurement. Consult clinical resources for specific interpretation.
Pancreatic hormone regulating glucose uptake. Fasting hyperinsulinemia suggests insulin resistance.
Amino acid linked to B‑vitamin metabolism. Elevated levels associate with vascular risk and methylation defects.
High-sensitivity C-reactive protein (hs-CRP): A laboratory measurement. Consult clinical resources for specific interpretation.
Average glycemia over prior 8–12 weeks. Used to diagnose and monitor diabetes management.
Oxygen-carrying protein in red blood cells. Low hemoglobin indicates anemia and reduced oxygen delivery. High levels may reflect dehydration or polycythemia.
The proportion of blood volume occupied by red blood cells. Low values indicate anemia. High values suggest dehydration or polycythemia.
HDL-Cholesterol: A laboratory measurement. Consult clinical resources for specific interpretation.
HDL Large refers to the larger, more protective subfraction of high-density lipoprotein (HDL) particles involved in cholesterol transport.
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
Serum glucose is the level of sugar in the blood and serves as the body’s primary source of energy.
Primary circulating sugar. Fasting elevation signals insulin resistance, prediabetes, or diabetes.
Globulin: A laboratory measurement. Consult clinical resources for specific interpretation.
Gamma‑glutamyl transferase, sensitive to biliary injury and alcohol exposure. Elevated in cholestasis.
Active thyroid hormone affecting metabolism. Used in detailed thyroid evaluation.
Proportion of eosinophils, associated with allergic responses and parasitic infections.
Unbound thyroxine hormone. Low levels suggest hypothyroidism, high indicate hyperthyroidism.
Follicle-stimulating hormone driving follicle development and spermatogenesis. Abnormal levels indicate gonadal dysfunction.
Primary estrogen regulating reproductive and bone health. Levels vary by sex, age, and cycle phase.
Iron storage protein indicating iron stores. Low ferritin indicates deficiency, high may reflect inflammation or iron overload.
Adrenal steroid precursor reflecting adrenal androgen production. Altered levels occur in adrenal or gonadal disorders.
Estimated glomerular filtration rate assessing kidney filtration capacity. Lower values indicate impaired renal function.
A muscle metabolism byproduct cleared by kidneys. Elevated serum creatinine suggests reduced glomerular filtration.
Morning cortisol reflecting HPA axis activity. Abnormal levels indicate adrenal dysfunction or stress adaptation issues.
Urine color is a visual indicator of hydration status and possible underlying health conditions.
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
A key electrolyte that reflects bicarbonate levels and helps regulate the body’s acid–base (pH) balance.
Carbon dioxide (bicarbonate, CO₂): A laboratory measurement. Consult clinical resources for specific interpretation.
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
Urea concentration reflecting protein metabolism and renal excretion. Elevated in renal impairment or volume depletion.
An algorithmic estimate of physiological age derived from biomarker patterns and clinical data. Used to track aging-related changes relative to chronological age.
A urine marker that detects bilirubin, a byproduct of red blood cell breakdown, used to assess liver and bile duct health.
Proportion of basophils, involved in allergic reactions and histamine release.
Discover your starting point
Measure, compare and improve
Discover your starting point
Measure, compare and improve